JPH0160452B2 - - Google Patents
Info
- Publication number
- JPH0160452B2 JPH0160452B2 JP15246688A JP15246688A JPH0160452B2 JP H0160452 B2 JPH0160452 B2 JP H0160452B2 JP 15246688 A JP15246688 A JP 15246688A JP 15246688 A JP15246688 A JP 15246688A JP H0160452 B2 JPH0160452 B2 JP H0160452B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- valproic acid
- acetone
- present
- valproate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 25
- 229960000604 valproic acid Drugs 0.000 claims description 17
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 206010010904 Convulsion Diseases 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 229940084026 sodium valproate Drugs 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 230000036461 convulsion Effects 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 238000002636 symptomatic treatment Methods 0.000 claims description 2
- 206010015037 epilepsy Diseases 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- -1 alkali metal salts Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15246688A JPS6425718A (en) | 1988-06-22 | 1988-06-22 | Oral solid drug for treating syndrome of epilepsy or spasm |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15246688A JPS6425718A (en) | 1988-06-22 | 1988-06-22 | Oral solid drug for treating syndrome of epilepsy or spasm |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6425718A JPS6425718A (en) | 1989-01-27 |
| JPH0160452B2 true JPH0160452B2 (enrdf_load_stackoverflow) | 1989-12-22 |
Family
ID=15541128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15246688A Granted JPS6425718A (en) | 1988-06-22 | 1988-06-22 | Oral solid drug for treating syndrome of epilepsy or spasm |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6425718A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3768203B2 (ja) | 2003-05-19 | 2006-04-19 | 昇太郎 望月 | 動物用排泄物処理材 |
-
1988
- 1988-06-22 JP JP15246688A patent/JPS6425718A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6425718A (en) | 1989-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5212326A (en) | Sodium hydrogen divalproate oligomer | |
| US4988731A (en) | Sodium hydrogen divalproate oligomer | |
| CA2477923C (en) | Multiple-component solid phases containing at least one active pharmaceutical ingredient | |
| JPS5912650B2 (ja) | フエニル脂肪族飽和カルボン酸の塩類の製造法 | |
| JP2016504277A (ja) | ピロロキノリンキノン二ナトリウム塩の結晶 | |
| EP0271709B1 (en) | Salt of diclofenac with a cyclic organic base and pharmaceutical compositions which contain it | |
| US4073895A (en) | Isopropylamino pyrimidine orthophosphate | |
| EP0034172B1 (en) | Mixed salt of valproic acid | |
| JPH0160452B2 (enrdf_load_stackoverflow) | ||
| US4973553A (en) | Salt or organogermanium compound and medicine containing the same | |
| JPS643178B2 (enrdf_load_stackoverflow) | ||
| HU187922B (en) | Process for preparing 3-/n,n-dimethyl-carbamoyl/-pyrazolo/1,5-a/-pyridine | |
| EP1264821B1 (en) | Novel crystal of stilbene derivative and process for producing the same | |
| EP2909169B1 (en) | Crystalline phase of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) with l-lysine | |
| JPS61280451A (ja) | 新規なアセチルサリチル酸誘導体、それの製法およびそれを含有している製薬学的組成物類 | |
| JPS6281365A (ja) | グアニジノエタンチオスルホン酸、その製造法、及びそれを含有するコレステロ−ル低下剤 | |
| EP0923932B1 (en) | Composition containing antitumor agent | |
| US4559360A (en) | Cysteine derivatives, a process for their preparation, and pharmaceutical compositions which contain them | |
| JPS5910563A (ja) | α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法 | |
| EP0096013B1 (en) | Salts of erythromycin showing a combined therapeutic activity, process for their preparation and pharmaceutical formulations containing them | |
| JPH05310686A (ja) | Ｓ−カルボキシメチルシステインリジンモノハイドレートおよびその調製方法 | |
| CA1296277C (en) | Salt of organogermanium compound and medicine containing the same | |
| JPS6160066B2 (enrdf_load_stackoverflow) | ||
| US4239771A (en) | Water-soluble salts of tienilic acid | |
| PL117861B1 (en) | Process for preparing novel derivatives of phthalaz-1-one |